These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 37460842)

  • 1. Liver insulinization as a driver of triglyceride dysmetabolism.
    Cook JR; Hawkins MA; Pajvani UB
    Nat Metab; 2023 Jul; 5(7):1101-1110. PubMed ID: 37460842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction and Validation of Metabolic Dysfunction-Associated Fatty Liver Disease Using Insulin Resistance-Related Indices in the Japanese Population.
    Moriyama K; Inoue N; Imai J; Masuda Y; Yamada C; Kishimoto N; Takashimizu S; Kubo A; Nishizaki Y
    Metab Syndr Relat Disord; 2023 Nov; 21(9):489-496. PubMed ID: 37878804
    [No Abstract]   [Full Text] [Related]  

  • 3. Insulin resistance and adipose tissue interactions as the cornerstone of metabolic (dysfunction)-associated fatty liver disease pathogenesis.
    Pal SC; Méndez-Sánchez N
    World J Gastroenterol; 2023 Jul; 29(25):3999-4008. PubMed ID: 37476582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin's direct hepatic effect explains the inhibition of glucose production caused by insulin secretion.
    Edgerton DS; Kraft G; Smith M; Farmer B; Williams PE; Coate KC; Printz RL; O'Brien RM; Cherrington AD
    JCI Insight; 2017 Mar; 2(6):e91863. PubMed ID: 28352665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin's effect on the liver: "direct or indirect?" continues to be the question.
    Girard J
    J Clin Invest; 2006 Feb; 116(2):302-4. PubMed ID: 16453016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired Glucagon-Mediated Suppression of VLDL-Triglyceride Secretion in Individuals With Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD).
    Heebøll S; Risikesan J; Ringgaard S; Kumarathas I; Sandahl TD; Grønbæk H; Søndergaard E; Nielsen S
    Diabetes; 2022 Nov; 71(11):2402-2411. PubMed ID: 36001750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gracilaria chorda subcritical water ameliorates hepatic lipid accumulation and regulates glucose homeostasis in a hepatic steatosis cell model and obese C57BL/6J mice.
    Thakuri LS; Park CM; Kim HA; Kim HJ; Park JW; Park JC; Rhyu DY
    J Ethnopharmacol; 2024 Feb; 320():117395. PubMed ID: 37952731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin signaling is required for insulin's direct and indirect action on hepatic glucose production.
    Fisher SJ; Kahn CR
    J Clin Invest; 2003 Feb; 111(4):463-8. PubMed ID: 12588884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial: Treatment with Dual Incretin Receptor Agonists to Maintain Normal Glucose Levels May Also Maintain Normal Weight and Control Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD).
    Ordóñez-Vázquez AL; Beltrán-Gall SM; Pal SC; Méndez-Sánchez N
    Med Sci Monit; 2022 Sep; 28():e938365. PubMed ID: 36093924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the liver in the modulation of glucose and insulin in non alcoholic fatty liver disease and type 2 diabetes.
    Guerra S; Gastaldelli A
    Curr Opin Pharmacol; 2020 Dec; 55():165-174. PubMed ID: 33278735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to leptin action is the major determinant of hepatic triglyceride accumulation in vivo.
    Fishman S; Muzumdar RH; Atzmon G; Ma X; Yang X; Einstein FH; Barzilai N
    FASEB J; 2007 Jan; 21(1):53-60. PubMed ID: 17099068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcitriol Reduces Hepatic Triglyceride Accumulation and Glucose Output Through Ca2+/CaMKKβ/AMPK Activation Under Insulin-Resistant Conditions in Type 2 Diabetes Mellitus.
    Cheng S; So WY; Zhang D; Cheng Q; Boucher BJ; Leung PS
    Curr Mol Med; 2016; 16(8):747-758. PubMed ID: 27658467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interrelationships among insulin's antilipolytic and glucoregulatory effects and plasma triglycerides in nondiabetic and diabetic patients with endogenous hypertriglyceridemia.
    Yki-Järvinen H; Taskinen MR
    Diabetes; 1988 Sep; 37(9):1271-8. PubMed ID: 3044892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding.
    Oakes ND; Cooney GJ; Camilleri S; Chisholm DJ; Kraegen EW
    Diabetes; 1997 Nov; 46(11):1768-74. PubMed ID: 9356024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Insulin Resistance in MAFLD.
    Sakurai Y; Kubota N; Yamauchi T; Kadowaki T
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33923817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triglycerides in Nonalcoholic Fatty Liver Disease: Guilty Until Proven Innocent.
    Semova I; Biddinger SB
    Trends Pharmacol Sci; 2021 Mar; 42(3):183-190. PubMed ID: 33468321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of hepatic insulin action in obese type 2 diabetic patients.
    Staehr P; Hother-Nielsen O; Levin K; Holst JJ; Beck-Nielsen H
    Diabetes; 2001 Jun; 50(6):1363-70. PubMed ID: 11375337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.
    Marchesini G; Brizi M; Bianchi G; Tomassetti S; Bugianesi E; Lenzi M; McCullough AJ; Natale S; Forlani G; Melchionda N
    Diabetes; 2001 Aug; 50(8):1844-50. PubMed ID: 11473047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes.
    Perry RJ; Camporez JG; Kursawe R; Titchenell PM; Zhang D; Perry CJ; Jurczak MJ; Abudukadier A; Han MS; Zhang XM; Ruan HB; Yang X; Caprio S; Kaech SM; Sul HS; Birnbaum MJ; Davis RJ; Cline GW; Petersen KF; Shulman GI
    Cell; 2015 Feb; 160(4):745-758. PubMed ID: 25662011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to insulin's acute direct hepatic effect in suppressing steady-state glucose production in individuals with type 2 diabetes.
    Lewis GF; Carpentier A; Vranic M; Giacca A
    Diabetes; 1999 Mar; 48(3):570-6. PubMed ID: 10078558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.